GlassScriptPhysician profile
Roger A Alvarez
NPI 1457593832
$81,661.54
in general payments reported to CMS, 2019-2025
15 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,588 · 2020: $230 · 2021: $2,265 · 2022: $9,634 · 2023: $18K · 2024: $16K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Travel and Lodging: $5,887 · Food and Beverage: $3,960 · Education: $98.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,000.00 |
| Travel and Lodging | $5,886.82 |
| Food and Beverage | $3,959.88 |
| Education | $98.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $69,369.53 | 2019-2025 | Tyvaso, Tyvaso |
| Penumbra, INC. | $9,973.22 | 2022-2023 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $886.78 | 2023-2025 | Uptravi, Opsumit |
| Inari Medical, INC. | $384.46 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.39 | 2020-2025 | Ofev |
| Merck Sharp & Dohme LLC | $145.00 | 2022 | |
| Atricure, INC. | $110.04 | 2025 | Atricure Cryoice Cryoablation System (Cryo2) |
| Boston Scientific Corporation | $109.32 | 2022 | |
| Argon Medical Devices, INC. | $100.90 | 2025 | Clot Management |
| Angiodynamics, INC. | $95.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.07 | 2023-2024 | |
| Intuitive Surgical, INC. | $64.50 | 2024 | |
| Glaxosmithkline, LLC. | $38.58 | 2023 | Trelegy Ellipta |
| Mallinckrodt Hospital Products INC. | $34.81 | 2024 | Acthar |
| Genentech, INC. | $16.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.